Procurement Summary
Country : USA
Summary : Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)
Deadline : 07 May 2021
Other Information
Notice Type : Tender
TOT Ref.No.: 20949244
Document Ref. No. : PA-18-678
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
USA
Email :FBOWebmaster@OD.NIH.GOV
Tender Details
Tender are invited for Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)
CFDA Number : 93.393 -- Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: May 07, 2021
Posted Date : Feb 23, 2018
Description: The purpose of this concept initiative is to promote etiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States.
Documents
Tender Notice